Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE826.705.15 (+0.63 %)

PREV CLOSE ( ) 821.55

OPEN PRICE ( ) 829.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 56821

TODAY'S LOW / HIGH ( )814.80 829.95

52 WK LOW / HIGH ( )390.3 834.45

NSE827.005.5 (+0.67 %)

PREV CLOSE( ) 821.50

OPEN PRICE ( ) 825.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 827.00 (59)

VOLUME 989477

TODAY'S LOW / HIGH( ) 814.50 829.00

52 WK LOW / HIGH ( )414 834.35

Chairman	Ravindranath Kancherla
Company Secretary	G Venkateswar Reddy
Executive Director	CV Lakshmana Rao Krishna Chaitanya Chava Soumya Chava
Non Executive Independent Director	Aruna Bhinge Rajesh Koshy Chandy Karnam Sekar Ramesh Subrahmanian
Whole Time Director	Satyanarayana Chava V Ravi Kumar

Incorporation Year : 19-09 2005

Registered Office :

Address : Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli Vishakhapatnam,
Andhra Pradesh-531021 .

Phone : 0891 6821101 / 1102

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE